Advertisement

Legal System Involvement and Opioid-Related Overdose Mortality in U.S. Department of Veterans Affairs Patients

Published:September 12, 2021DOI:https://doi.org/10.1016/j.amepre.2021.06.014

      Introduction

      Opioid-related overdose risks are elevated after incarceration. The rates of opioid-related overdose mortality have risen in recent years, including among Veterans Health Administration patients. To inform Veteran overdose prevention, this study evaluates whether opioid-related overdose risks differ for Veterans Health Administration patients with versus those without indicators of legal system involvement.

      Methods

      This retrospective national cohort study, conducted in 2019–2021, used Veterans Health Administration electronic health records and death certificate data from the Department of Veterans Affairs/Department of Defense Mortality Data Repository to examine opioid-related overdose mortality from January 1, 2013 through December 31, 2017. The cohort included 5,390,902 Veterans with Veterans Health Administration inpatient or outpatient encounters in 2012 who were alive as of January 1, 2013, of whom 32,284 (0.60%) patients had legal system involvement in 2012, indicated by Veterans Justice Programs outpatient encounters. Cox proportional hazards regression models assessed the associations between legal involvement and risk of opioid-related overdose mortality.

      Results

      There were 4,670 opioid-related overdose deaths, including 295 (6.31%) among legal-involved Veterans. Veterans with legal involvement had a higher opioid-related overdose mortality rate per 100,000 person-years (191.22, 95% CI=169.40, 213.04 vs 17.76, 95% CI=17.23, 18.29, p<0.001) and an elevated risk of opioid-related overdose mortality (adjusted hazard ratio=1.38, 95% CI=1.22, 1.57, p<0.001) compared with those without.

      Conclusions

      Among Veterans receiving Veterans Health Administration care in 2012, documented legal system involvement was associated with an increased risk of opioid-related overdose mortality. Targeting overdose education and naloxone distribution programs and integrating opioid overdose prevention efforts into mental health care may reduce opioid overdose deaths among Veterans with legal involvement.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Wilson N
        • Kariisa M
        • Seth P
        • Smith 4th, H
        • Davis NL
        Drug and opioid-involved overdose deaths - United States, 2017-2018.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 290-297https://doi.org/10.15585/mmwr.mm6911a4
        • Binswanger IA
        • Blatchford PJ
        • Mueller SR
        • Stern MF.
        Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.
        Ann Intern Med. 2013; 159: 592-600https://doi.org/10.7326/0003-4819-159-9-201311050-00005
        • Ranapurwala SI
        • Shanahan ME
        • Alexandridis AA
        • et al.
        Opioid overdose mortality among former North Carolina inmates: 2000-2015.
        Am J Public Health. 2018; 108: 1207-1213https://doi.org/10.2105/AJPH.2018.304514
        • Pizzicato LN
        • Drake R
        • Domer-Shank R
        • Johnson CC
        Viner KMBeyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons.
        Drug Alcohol Depend. 2018; 189: 108-115https://doi.org/10.1016/j.drugalcdep.2018.04.034
        • Wortzel HS
        • Blatchford P
        • Conner L
        • Adler LE
        • Binswanger IA.
        Risk of death for veterans on release from prison.
        J Am Acad Psychiatry Law. 2012; 40: 348-354
        http://www.ncbi.nlm.nih.gov/pubmed/22960917
        Date accessed: April 14, 2014
        • Joudrey PJ
        • Khan MR
        • Wang EA
        • et al.
        A conceptual model for understanding post-release opioid-related overdose risk.
        Addict Sci Clin Pract. 2019; 14: 17https://doi.org/10.1186/s13722-019-0145-5
        • Finlay AK
        • Morse E
        • Stimmel M
        • et al.
        Barriers to medications for opioid use disorder among veterans involved in the legal system: a qualitative study.
        J Gen Intern Med. 2020; 35: 2529-2536https://doi.org/10.1007/s11606-020-05944-6
        • Binswanger IA
        • Nguyen AP
        • Morenoff JD
        • Xu S
        • Harding DJ.
        The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study.
        Addiction. 2020; 115: 2329-2338https://doi.org/10.1111/add.15077
        • Volkow ND
        • Jones EB
        • Einstein EB
        • Wargo EM.
        Prevention and treatment of opioid misuse and addiction: a review.
        JAMA Psychiatry. 2019; 76: 208-216https://doi.org/10.1001/jamapsychiatry.2018.3126
        • Finlay AK
        • Harris AHS
        • Timko C
        • et al.
        Disparities in access to medications for opioid use disorder in the Veterans Health Administration.
        J Addict Med. 2021; 15: 143-149https://doi.org/10.1097/ADM.0000000000000719
        • Finlay AK
        • Harris AH
        • Rosenthal J
        • et al.
        Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.
        Drug Alcohol Depend. 2016; 160: 222-226https://doi.org/10.1016/j.drugalcdep.2016.01.013
        • Gellad WF
        • Good CB
        • Shulkin DJ.
        Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs.
        JAMA Intern Med. 2017; 177: 611-612https://doi.org/10.1001/jamainternmed.2017.0147
        • Oliva EM
        • Christopher MLD
        • Wells D
        • et al.
        Opioid overdose education and naloxone distribution: development of the Veterans Health Administration's national program.
        J Am Pharm Assoc (2003). 2017; 57 (e4): S168-S179https://doi.org/10.1016/j.japh.2017.01.022
        • Dumont DM
        • Brockmann B
        • Dickman S
        • Alexander N
        • Rich JD
        Public health and the epidemic of incarceration.
        Annu Rev Public Health. 2012; 33: 325-339https://doi.org/10.1146/annurev-publhealth-031811-124614
        • Malta M
        • Varatharajan T
        • Russell C
        • Pang M
        • Bonato S
        • Fischer B.
        Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review.
        PLoS Med. 2019; 16e1003002https://doi.org/10.1371/journal.pmed.1003002
        • Blue-Howells JH
        • Clark SC
        • van den Berk-Clark C
        • McGuire JF.
        The U.S. Department of Veterans Affairs Veterans Justice Programs and the sequential intercept model: case examples in national dissemination of intervention for justice-involved veterans.
        Psychol Serv. 2013; 10: 48-53https://doi.org/10.1037/a0029652
        • Finlay AK
        • Smelson D
        • Sawh L
        • et al.
        U.S. Department of Veterans Affairs Veterans Justice Outreach program: connecting justice-involved veterans with mental health and substance use disorder treatment.
        Crim Justice Policy Rev. 2016; 27: 203-222https://doi.org/10.1177/0887403414562601
        • Finlay AK
        • Stimmel M
        • Blue-Howells J
        • et al.
        Use of Veterans Health Administration mental health and substance use disorder treatment after exiting prison: the Health Care for Reentry Veterans Program.
        Adm Policy Ment Health. 2017; 44: 177-187https://doi.org/10.1007/s10488-015-0708-z
        • Palframan KM
        • Blue-Howells J
        • Clark SC
        • McCarthy JF.
        Veterans Justice Programs: assessing population risks for suicide deaths and attempts.
        Suicide Life Threat Behav. 2020; 50: 792-804https://doi.org/10.1111/sltb.12631
        • Defense Suicide Prevention Office (DSPO), U.S. Department of Defense
        The suicide data repository (SDR) fact sheet.
        Defense Suicide Prevention Office (DSPO), U.S. Department of Defense, Arlington, VAPublished 2020
        • Cowper DC
        • Kubal JD
        • Maynard C
        • Hynes DM.
        A primer and comparative review of major U.S. mortality databases.
        Ann Epidemiol. 2002; 12: 462-468https://doi.org/10.1016/S1047-2797(01)00285-X
        • Oliva EM
        • Bowe T
        • Tavakoli S
        • et al.
        Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide.
        Psychol Serv. 2017; 14: 34-49https://doi.org/10.1037/ser0000099
        • Baldwin JM
        • Hartley RD
        • Brooke EJ.
        Identifying those who served: modeling potential participant identification in Veterans Treatment Courts.
        Drug Court Rev. 2018; 1: 11-32
        • Christy A
        • Clark C
        • Frei A
        • Rynearson-Moody S.
        Challenges of diverting veterans to trauma informed care.
        Crim Justice Behav. 2012; 39: 461-474https://doi.org/10.1177/0093854811433539
      1. Welcome to the veterans re-entry search services. U.S. Department of Veterans Affairs. https://vrss.va.gov/. Accessed September 7, 2021.

        • Murphy SL
        • Xu J
        • Kochanek KD.
        Deaths: final data for 2010.
        Natl Vital Stat Rep. 2013; 61: 1-117
      2. SAS/ACCESS® 9.4 Interface to ADABAS: Reference [computer program].
        SAS Institute Inc., Cary, NC2013
        • Bird SM
        • McAuley A
        • Perry S
        • Hunter C.
        Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006–10) versus after (2011–13) comparison.
        Addiction. 2016; 111: 883-891https://doi.org/10.1111/add.13265
        • Brinkley-Rubinstein L
        • Zaller N
        • Martino S
        • et al.
        Criminal justice continuum for opioid users at risk of overdose.
        Addict Behav. 2018; 86: 104-110https://doi.org/10.1016/j.addbeh.2018.02.024
        • Wenger LD
        • Showalter D
        • Lambdin B
        • et al.
        Overdose education and naloxone distribution in the San Francisco County jail.
        J Correct Health Care. 2019; 25: 394-404https://doi.org/10.1177/1078345819882771
        • Michaelson R.
        Cincinnati VA Veterans Justice Outreach (VJO) approach to OOEND. VA overdose education and naloxone distribution (OEND).
        Monthly Call. 2020; (Webinar)
        • Gicquelais RE
        • Mezuk B
        • Foxman B
        • Thomas L
        • Bohnert ASB.
        Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment.
        Harm Reduct J. 2019; 16: 46https://doi.org/10.1186/s12954-019-0317-3
        • Lin LA
        • Peltzman T
        • McCarthy JF
        • Oliva EM
        • Trafton JA
        • Bohnert ASB.
        Changing trends in opioid overdose deaths and prescription opioid receipt among veterans.
        Am J Prev Med. 2019; 57: 106-110https://doi.org/10.1016/j.amepre.2019.01.016
        • Sordo L
        • Barrio G
        • Bravo MJ
        • et al.
        Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
        BMJ. 2017; 357: j1550https://doi.org/10.1136/bmj.j1550
        • Ma J
        • Bao YP
        • Wang RJ
        • et al.
        Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
        Mol Psychiatry. 2019; 24: 1868-1883https://doi.org/10.1038/s41380-018-0094-5
        • Degenhardt L
        • Bucello C
        • Mathers B
        • et al.
        Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.
        Addiction. 2011; 106: 32-51https://doi.org/10.1111/j.1360-0443.2010.03140.x
        • Schwartz RP
        • Kelly SM
        • Mitchell SG
        • O'Grady KE
        • Sharma A
        • Jaffe JH
        Methadone treatment of arrestees: a randomized clinical trial.
        Drug Alcohol Depend. 2020; 206107680https://doi.org/10.1016/j.drugalcdep.2019.107680
        • Rich JD
        • McKenzie M
        • Larney S
        • et al.
        Methadone continuation versus forced withdrawal on incarceration in a combined U.S. prison and jail: a randomised, open-label trial.
        Lancet. 2015; 386: 350-359https://doi.org/10.1016/S0140-6736(14)62338-2
        • Degenhardt L
        • Larney S
        • Kimber J
        • et al.
        The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
        Addiction. 2014; 109: 1306-1317https://doi.org/10.1111/add.12536
        • Sugarman OK
        • Bachhuber MA
        • Wennerstrom A
        • Bruno T
        • Springgate BF.
        Interventions for incarcerated adults with opioid use disorder in the United States: a systematic review with a focus on social determinants of health.
        PLoS One. 2020; 15e0227968https://doi.org/10.1371/journal.pone.0227968
        • Green TC
        • Clarke J
        • Brinkley-Rubinstein L
        • et al.
        Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system.
        JAMA Psychiatry. 2018; 75: 405-407https://doi.org/10.1001/jamapsychiatry.2017.4614
        • Wong ES
        • Wang V
        • Liu CF
        • Hebert PL
        • Maciejewski ML.
        Do Veterans Health Administration enrollees generalize to other populations?.
        Med Care Res Rev. 2016; 73: 493-507https://doi.org/10.1177/1077558715617382
        • Krawczyk N
        • Mojtabai R
        • Stuart EA
        • et al.
        Opioid agonist treatment and fatal overdose risk in a state-wide U.S. population receiving opioid use disorder services.
        Addiction. 2020; 115: 1683-1694https://doi.org/10.1111/add.14991
        • Vail W
        • Faro E
        • Watnick D
        • Giftos J
        • Fox AD.
        Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail.
        Drug Alcohol Depend. 2021; 222108529https://doi.org/10.1016/j.drugalcdep.2021.108529
        • Park TW
        • Saitz R
        • Ganoczy D
        • Ilgen MA
        • Bohnert AS.
        Benzodiazepine prescribing patterns and deaths from drug overdose among U.S. veterans receiving opioid analgesics: case-cohort study.
        BMJ. 2015; 350: h2698https://doi.org/10.1136/bmj.h2698
        • Binswanger IA
        • Stern MF
        • Yamashita TE
        • Mueller SR
        • Baggett TP
        • Blatchford PJ.
        Clinical risk factors for death after release from prison in Washington State: a nested case-control study.
        Addiction. 2016; 111: 499-510https://doi.org/10.1111/add.13200
        • Gan WQ
        • Kinner SA
        • Nicholls TL
        • et al.
        Risk of overdose-related death for people with a history of incarceration.
        Addiction. 2021; 116: 1460-1471https://doi.org/10.1111/add.15293
        • Blue-Howells J
        • Timko C
        • Clark S
        • Finlay AK.
        Criminal justice issues among homeless veterans.
        in: Tsai J Homelessness Among U.S. Veterans: Critical Perspectives. ed. Oxford University Press, Oxford, United Kingdom2018https://doi.org/10.1093/oso/9780190695132.003.0006
        • Binswanger IA
        • Stern MF
        • Deyo RA
        • et al.
        Release from prison–a high risk of death for former inmates [published correction appears in N Engl J Med. 2007;356(5):536].
        N Engl J Med. 2007; 356: 157-165https://doi.org/10.1056/NEJMsa064115
        • Boden MT
        • Hoggatt KJ.
        Substance use disorders among veterans in a nationally representative sample: prevalence and associated functioning and treatment utilization.
        J Stud Alcohol Drugs. 2018; 79: 853-861https://doi.org/10.15288/jsad.2018.79.853
        • Wu LT
        • Zhu H
        • Swartz MS
        Treatment utilization among persons with opioid use disorder in the United States.
        Drug Alcohol Depend. 2016; 169: 117-127https://doi.org/10.1016/j.drugalcdep.2016.10.015
        • Farmer CM
        • Hosek SD
        • Adamson DM
        Balancing demand and supply for veterans’ health care: a summary of three RAND assessments conducted under the Veterans Choice Act.
        Rand Health Q. 2016; 6: 12https://doi.org/10.7249/rr1165.4